CDEK
← All organizations

EVIVE Biotechnology

For profitContributed to NME

Also known as: EVIVE Biotechnology | EVIVE BIOTECHNOLOGY | Evive Biotechnology Singapore PTE. LTD.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Dec 31, 2020

First marketed drug

Nov 16, 2023

First NDA

Nov 16, 2023

Last known activity

Nov 16, 2023

Timeline

2000s

  1. Jan 1, 2004

    EVIVE Biotechnology— Founded

2020s

  1. Nov 16, 2023

    Efbemalenograstim alpha— NDA Organization

Drugs by trial phase (1 distinct, 2 trials)

Phase 2 (1 own, 0 via acquisition)

Marketed drugs (1)

Recent trials (2)

Details

Founded
Singapore, SG Jan 1, 2004
First NDA
Nov 16, 2023
Last known activity
Nov 16, 2023